North America Human Growth Hormone Market By Application (Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy) By Country, Industry Analysis and Forecast, 2019 - 2025
The North America Human Growth Hormone Market would witness market growth of 7.7% CAGR during the forecast period (2019-2025).
Growth hormone (GH) is a substance in the body that helps children grow and mature. It is made by a pituitary gland, which is a small gland between the lobes of the brain. Growth Hormone Deficiency (GHD) is a well-known clinical condition in adults. It is characterized by defects in the metabolism of the substrate, body composition, physical and psychosocial functioning, all of which increase after GH replacement. Idiopathic short stature (ISS) is more a clinical term than a disorder. ISS is generally considered to be a normal growth variant (because pathological causes are excluded by definition). Certain common variants are familial short stature (FSS) and constitutional retardation of growth and puberty (CDGP), often referred to as constitutional short stature for pre-pubertal children.
The United States industry for human growth hormones has been witnessing substantial growth. The dominance of this region can be linked to factors like high spending on healthcare, high prevalence of target illnesses, and the availability of reimbursements. Turner Syndrome is an uncommon chromosomal disorder that harms females and is defined by a partial or complete loss of one of the X chromosomes. Symptoms of Turner syndrome are a wide neck and low or indistinct hairline, vulnerability to high blood pressure, minor eye problems, eyelid drops, and underactive thyroid gland. The age of diagnosis dropped significantly with a greater understanding of Turner Syndrome in the medical community, which, in turn, is fueling the market. As it is associated with several complications related to heart disease, autoimmune disorders, hearing loss, mental health problems, infertility and pregnancy complications, the demand for growth hormone treatment is rising.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
Growth hormone (GH) is a substance in the body that helps children grow and mature. It is made by a pituitary gland, which is a small gland between the lobes of the brain. Growth Hormone Deficiency (GHD) is a well-known clinical condition in adults. It is characterized by defects in the metabolism of the substrate, body composition, physical and psychosocial functioning, all of which increase after GH replacement. Idiopathic short stature (ISS) is more a clinical term than a disorder. ISS is generally considered to be a normal growth variant (because pathological causes are excluded by definition). Certain common variants are familial short stature (FSS) and constitutional retardation of growth and puberty (CDGP), often referred to as constitutional short stature for pre-pubertal children.
The United States industry for human growth hormones has been witnessing substantial growth. The dominance of this region can be linked to factors like high spending on healthcare, high prevalence of target illnesses, and the availability of reimbursements. Turner Syndrome is an uncommon chromosomal disorder that harms females and is defined by a partial or complete loss of one of the X chromosomes. Symptoms of Turner syndrome are a wide neck and low or indistinct hairline, vulnerability to high blood pressure, minor eye problems, eyelid drops, and underactive thyroid gland. The age of diagnosis dropped significantly with a greater understanding of Turner Syndrome in the medical community, which, in turn, is fueling the market. As it is associated with several complications related to heart disease, autoimmune disorders, hearing loss, mental health problems, infertility and pregnancy complications, the demand for growth hormone treatment is rising.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
- Small for Gestational Age
- Prader-Willi Syndrome
- Idiopathic Short Stature
- Turner Syndrome
- Growth Hormone Deficiency
- Pediatric Growth Hormone Deficiency
- Adult Growth Hormone Deficiency
- Other Applications
- Retail Pharmacy
- Hospital Pharmacy
- Specialty Pharmacy
- Online Pharmacy
- US
- Canada
- Mexico
- Rest of North America
- Merck Group
- Teva Pharmaceuticals Industries Ltd.
- Ipsen Pharma Biotech SAS
- Novartis AG (Sandoz International GmbH)
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
- Ferring Holdings SA
- Novo Nordisk A/S
- Eli Lilly and Company
- Anhui Anke Biotechnology Group Co., Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Human Growth Hormone Market, by Application
1.4.2 North America Growth Hormone Deficiency Application Market, by Type
1.4.3 North America Human Growth Hormone Market, by Distribution Channel
1.4.4 North America Human Growth Hormone Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION
3.1 North America Small for Gestational Age Market by Country
3.2 North America Prader-Willi Syndrome Market by Country
3.3 North America Idiopathic Short Stature Market by Country
3.4 North America Turner Syndrome Market by Country
3.5 North America Growth Hormone Deficiency Market by Country
3.5.1 North America Growth Hormone Deficiency Application Market by Type
3.5.1.1 North America Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 North America Adult Growth Hormone Deficiency Market by Country
3.5.2 North America Other Applications Market by Country
CHAPTER 4. NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL
4.1 North America Retail Pharmacy Market by Country
4.2 North America Hospital Pharmacy Market by Country
4.3 North America Specialty Pharmacy Market by Country
4.4 North America Online Pharmacy Market by Country
CHAPTER 5. NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY COUNTRY
5.1 USA Human Growth Hormone Market
5.1.1 USA Human Growth Hormone Market by Application
5.1.1.1 USA Growth Hormone Deficiency Application Market by Type
5.1.2 USA Human Growth Hormone Market by Distribution Channel
5.2 Canada Human Growth Hormone Market
5.2.1 Canada Human Growth Hormone Market by Application
5.2.1.1 Canada Growth Hormone Deficiency Application Market by Type
5.2.2 Canada Human Growth Hormone Market by Distribution Channel
5.3 Mexico Human Growth Hormone Market
5.3.1 Mexico Human Growth Hormone Market by Application
5.3.1.1 Mexico Growth Hormone Deficiency Application Market by Type
5.3.2 Mexico Human Growth Hormone Market by Distribution Channel
5.4 Rest of North America Human Growth Hormone Market
5.4.1 Rest of North America Human Growth Hormone Market by Application
5.4.1.1 Rest of North America Growth Hormone Deficiency Application Market by Type
5.4.2 Rest of North America Human Growth Hormone Market by Distribution Channel
CHAPTER 6. COMPANY PROFILES
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Human Growth Hormone Market, by Application
1.4.2 North America Growth Hormone Deficiency Application Market, by Type
1.4.3 North America Human Growth Hormone Market, by Distribution Channel
1.4.4 North America Human Growth Hormone Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION
3.1 North America Small for Gestational Age Market by Country
3.2 North America Prader-Willi Syndrome Market by Country
3.3 North America Idiopathic Short Stature Market by Country
3.4 North America Turner Syndrome Market by Country
3.5 North America Growth Hormone Deficiency Market by Country
3.5.1 North America Growth Hormone Deficiency Application Market by Type
3.5.1.1 North America Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 North America Adult Growth Hormone Deficiency Market by Country
3.5.2 North America Other Applications Market by Country
CHAPTER 4. NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL
4.1 North America Retail Pharmacy Market by Country
4.2 North America Hospital Pharmacy Market by Country
4.3 North America Specialty Pharmacy Market by Country
4.4 North America Online Pharmacy Market by Country
CHAPTER 5. NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY COUNTRY
5.1 USA Human Growth Hormone Market
5.1.1 USA Human Growth Hormone Market by Application
5.1.1.1 USA Growth Hormone Deficiency Application Market by Type
5.1.2 USA Human Growth Hormone Market by Distribution Channel
5.2 Canada Human Growth Hormone Market
5.2.1 Canada Human Growth Hormone Market by Application
5.2.1.1 Canada Growth Hormone Deficiency Application Market by Type
5.2.2 Canada Human Growth Hormone Market by Distribution Channel
5.3 Mexico Human Growth Hormone Market
5.3.1 Mexico Human Growth Hormone Market by Application
5.3.1.1 Mexico Growth Hormone Deficiency Application Market by Type
5.3.2 Mexico Human Growth Hormone Market by Distribution Channel
5.4 Rest of North America Human Growth Hormone Market
5.4.1 Rest of North America Human Growth Hormone Market by Application
5.4.1.1 Rest of North America Growth Hormone Deficiency Application Market by Type
5.4.2 Rest of North America Human Growth Hormone Market by Distribution Channel
CHAPTER 6. COMPANY PROFILES
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 USA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 USA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 USA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 USA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 USA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 USA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 USA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 USA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 CANADA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 CANADA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 CANADA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 CANADA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 CANADA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 CANADA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 MEXICO HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 MEXICO HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 MEXICO HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 MEXICO HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 MEXICO GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 MEXICO HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 KEY INFORMATION – MERCK GROUP
TABLE 68 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 69 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 70 KEY INFORMATION – NOVARTIS AG
TABLE 71 KEY INFORMATION – PFIZER, INC.
TABLE 72 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 73 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 74 KEY INFORMATION – NOVO NORDISK A/S
TABLE 75 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 76 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.
TABLE 1 NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 USA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 USA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 USA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 USA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 USA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 USA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 USA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 USA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 CANADA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 CANADA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 CANADA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 CANADA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 CANADA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 CANADA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 MEXICO HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 MEXICO HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 MEXICO HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 MEXICO HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 MEXICO GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 MEXICO HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 KEY INFORMATION – MERCK GROUP
TABLE 68 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 69 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 70 KEY INFORMATION – NOVARTIS AG
TABLE 71 KEY INFORMATION – PFIZER, INC.
TABLE 72 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 73 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 74 KEY INFORMATION – NOVO NORDISK A/S
TABLE 75 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 76 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
